SOTAC

Sotac Pharmaceuticals Ltd

₹115.00
-10 (-8%)
17 May, 2024 05:39 BSE: NSE: SOTACISIN: INE0O2D01012

Start SIP in Sotac Pharmaceuticals Ltd

Start SIP

Sotac Pharmaceuticals Ltd Performance

Day Range

  • Low 115
  • High 122
₹ 115

52 Week Range

  • Low 97
  • High 155
₹ 115
  • Open Price122
  • Previous Close125
  • Volume6000

Sotac Pharmaceuticals Ltd Share Price

  • Over 1 Month -5.74%
  • Over 3 Month -5.74%
  • Over 6 Month -9.41%
  • Over 1 Year -6.88%

Sotac Pharmaceuticals Ltd Key Statistics

P/E Ratio 34.6
PEG Ratio
Market Cap Cr 127
Price to Book Ratio 12.4
EPS 4.1
Dividend 0
Relative Strength Index 38.22
Money Flow Index 30.12
MACD Signal -1.42
Average True Range 4.79
Sotac Pharmaceuticals Ltd Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 18141913
Operating Expenses Qtr Cr 15121711
Operating Profit Qtr Cr 3322
Depreciation Qtr Cr 1100
Interest Qtr Cr 0000
Tax Qtr Cr 1001
Net Profit Qtr Cr 1211
IndicatorMar 2023
Total Revenue Annual Cr 58
Operating Expenses Annual Cr 50
Operating Profit Annual in Cr 8
Depreciation Cr 2
Interest Annual Cr 1
Tax Annual Cr 1
Net Profit Annual Cr 4
IndicatorMar 2023
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr -11
Cash from Financing Annual Activity Cr 12
Net Cash Flow Annual Cr 10
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 12
Fixed Assets Annual Cr 14
Total Non Current Assets Annual Cr 18
Total Current Assets Annual Cr 37
Total Assets Annual Cr 55
IndicatorMar 2023
Book Value Per Share Annual Rs 14
ROE Annual % 39
ROCE Annual % 25
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 15
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 26272518
Operating Expenses Qtr Cr 23252316
Operating Profit Qtr Cr 3222
Depreciation Qtr Cr 1111
Interest Qtr Cr 1001
Tax Qtr Cr 1010
Net Profit Qtr Cr 1111
IndicatorMar 2023
Total Revenue Annual Cr 78
Operating Expenses Annual Cr 70
Operating Profit Annual in Cr 7
Depreciation Cr 2
Interest Annual Cr 2
Tax Annual Cr 2
Net Profit Annual Cr 2
IndicatorMar 2023
Cash from Operating Activity Annual Cr 8
Cash from Investing Activity Annual Cr -12
Cash from Financing Annual Activity Cr 13
Net Cash Flow Annual Cr 10
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 10
Fixed Assets Annual Cr 24
Total Non Current Assets Annual Cr 27
Total Current Assets Annual Cr 47
Total Assets Annual Cr 74
IndicatorMar 2023
Book Value Per Share Annual Rs 13
ROE Annual % 23
ROCE Annual % 19
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 10

Sotac Pharmaceuticals Ltd Technicals

EMA & SMA

Current Price
₹115.00
-10 (-8%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • ₹125.90
  • 50 Day
  • ₹126.86
  • 100 Day
  • ₹125.73
  • 200 Day
  • 20 Day
  • ₹125.38
  • 50 Day
  • ₹127.78
  • 100 Day
  • ₹124.86
  • 200 Day

Sotac Pharmaceuticals Ltd Resistance and Support

PIVOT
₹117.85
Resistance
First Resistance 120.70
Second Resistance 124.85
Third Resistance 127.70
RSI 38.22
MFI 30.12
MACD Single Line -1.42
MACD -2.02
Support
First Support 113.70
Second Support 110.85
Third Supoort 106.70

Sotac Pharmaceuticals Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 6,000 600,000 100
Week 3,600 335,988 93.33
1 Month
6 Month 6,149 589,113 95.81

Sotac Pharmaceuticals Ltd Result Highlights

Sotac Pharmaceuticals Ltd Synopsis

NSE-Medical-Biomed/Biotech

Sotac Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 57.98 Cr. and Equity Capital is Rs. 8.05 Cr. for the Year ended 31/03/2023. Sotac Pharmaceuticals Ltd is a Public Limited Listed company incorporated on 18/12/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ2015PLC085451 and registration number is 085451.
Market Cap 129
Sales 64
Shares in Float 0.30
No of funds 3
Yield
Book Value 8.14
U/D Vol ratio 0.2
LTDebt / Equity 57
Alpha -0.1
Beta 0.66

Sotac Pharmaceuticals Ltd Shareholding Pattern

Owner NameMar-24Sep-23
Promoters 72.85%72.85%
Foreign Portfolio Investors 8.99%8.52%
Individual Investors 5.82%5.32%
Others 12.34%13.31%

Sotac Pharmaceuticals Ltd Management

Name Designation
Mr. Sharadkumar Dashrathbhai Patel Chairman & Managing Director
Mr. Dineshkumar Babulal Gelot Whole Time Director
Mr. Vishalkumar Devrajbhai Patel Executive Director
Mr. Chetankumar Bachubhai Patel Executive Director
Ms. Nidhiben Patel Ind. Non-Executive Director
Ms. Hetal Umangbhai Shah Ind. Non-Executive Director
Ms. Heena Viral Patel Ind. Non-Executive Director

Sotac Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sotac Pharmaceuticals Ltd Corporate Action

Date Purpose Remarks
2023-11-06 Quarterly Results
2023-05-29 Audited Results

Sotac Pharmaceuticals Ltd MF Shareholding

Name Amount(cr)

Sotac Pharmaceuticals Ltd FAQs

What is Share Price of Sotac Pharmaceuticals Ltd ?

Sotac Pharmaceuticals Ltd share price is ₹115 As on 17 May, 2024 | 05:25

What is the Market Cap of Sotac Pharmaceuticals Ltd ?

The Market Cap of Sotac Pharmaceuticals Ltd is ₹127.1 Cr As on 17 May, 2024 | 05:25

What is the P/E ratio of Sotac Pharmaceuticals Ltd ?

The P/E ratio of Sotac Pharmaceuticals Ltd is 34.6 As on 17 May, 2024 | 05:25

What is the PB ratio of Sotac Pharmaceuticals Ltd ?

The PB ratio of Sotac Pharmaceuticals Ltd is 12.4 As on 17 May, 2024 | 05:25

Q2FY23